Regen BioPharma Inc (RGBP)

[art35]

OTCShotCaller
10/24/22, 11:33 PM
$RGBP
Throughout 2023 I'm on track to build a 100M position preparing for the next Bull Run that will be preceded by a Market Recovery I believe will occur in early 2024. At first I viewed the Market Crash as disappointing, but now I see it as a once in a lifetime opportunity to buy a high market capacity stock at a 93% discount off its 52 Week High. RGBP is in the process of bringing multiple disruptive biotechnology patents to market that will play a role in the coming Paradigm Shift in Medicine with the promise of curing cancer by mRNA Vaccine Immunotherapy combining tCellVax to silence NR2F6. In contrast we saw Sloan Kettering patients in a clinical trial cured of colon cancer using an inferior monotherapy approach check point inhibitor dostarlimab as an Immunotherapy IV infusion. The mRNA Cancer Vaccine Market hit $47B in 2021 and is on track to hit $109B by 2028. There are two FDA approved mRNA Cancer Vaccines on the Market. Pfizer-Moderna- Merk seem to be leading the way so far.